TCL Archive NCI Develops Plan For Specialized Centers, But Funding $67.5M Program Depends On New $$ July 5, 1991
TCL Archive Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel April 12, 1974
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Diet Supplements Should Be Held To Scientific Standards, Broder Tells House August 6, 1993
